Randomized controlled trialHuman

Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation

AIDS (London, England), 2008 Sep 12. Falutz J, Allas S, Mamputu JC and 9 others.

Study type
Randomized controlled trial
Subjects
Human participants (PubMed MeSH: Humans)
Journal
AIDS (London, England)
Published
2008 Sep 12
PubMed
PMID 18690162 ↗
DOI
10.1097/QAD.0b013e32830a5058 ↗

Indexed under

MeSH terms assigned by the National Library of Medicine.

AdiponectinAnti-Retroviral AgentsBiomarkersBody CompositionC-Reactive ProteinCholesterolCross-Over StudiesFemaleGrowth Hormone-Releasing HormoneHIV-1HIV-Associated Lipodystrophy SyndromeHumans

PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page
Compounds